Category Archives: Specialty HUBs

Transaction Data System’s Next Phase of Growth to be Funded by BlackRock LTPC

Transaction Data Systems (TDS), a leader in pharmacy software solutions and services, announced that BlackRock Long Term Private Capital has acquired a majority interest in the company.

Lupin Pharmaceuticals Partnering with Phil, Inc. for its Patient Access Solution

By addressing patient access challenges using online technologies, as opposed to traditional call-center models, Phil Inc. partners with pharmaceutical manufacturers to deliver pioneering digital access to Specialty and Specialty-Lite therapies.

Avista Capital Partners Prepares to Divest United BioSource

Avista Capital Partners (Avista) is preparing to sell United BioSource Corporation (UBC), PE Hub reported. Avista acquired UBC in 2017 from Express Scripts. UBC, founded in 2003, is a market leader in providing integrated, comprehensive clinical, safety, and commercialization services. UBC brings together renowned scientific research and operations experts with leading-edge technologies, allowing for the best patient and […]

SCYNEXIS Partnering with Amplity Health to Launch BrexafemmeTM

SCYNEXIS announced that it has partnered with Amplity Health, a leading global contract commercialization organization, to support the anticipated U.S. commercialization of Brexafemme

Hub Service Providers First Quarter 2021 Activities (Part I)

Hub Service Providers first quarter 2021 activities include new solutions and acquisitions and investments

Recordati’s Isturisa for Cushing’s Disease Available Through AnovoRx

AnovoRx was created in 2012 by executives with significant experience in the specialty pharmacy and biopharmaceutical industry

Lumicera Specialty Pharmacy Expands Nationally With Purchase From CareMetx

The purchase of CareMetx’s specialty pharmacy will allow Lumicera to better serve patients located in the eastern United States

BioCryst’s Orladeyo Offers an Oral Treatment for HAE Patients

According to BioCryst Pharmaceuticals, the maker of Orladeyo, the medicine will be provided exclusively by specialty pharmacy Optime Care